| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 16, 2006
Accepted on December 1, 2006
Else Kröner-Fresenius-Center for Nutritional Medicine of the Technical University Munich, Germany; German Diabetes Clinic, German Diabetes Center, Leibniz Center at Heinrich-Heine-University Düsseldorf, D-40225 Düsseldorf, Germany
* To whom correspondence should be addressed. E-mail: nutritional.medicine{at}wzw.tum.de.
Context: Adipocytes are known to release a variety of factors that may contribute to the pro-inflammatory state characteristic for obesity. This secretory function is considered to provide the basis for obesity-related complications such as type 2 diabetes and atherosclerosis.
Objective: To get a better insight into possible underlying mechanisms we investigated the effect of adipocyte size on adipokine production and secretion.
Design, Patients and Main Outcome Measures: Protein secretion and mRNA expression in cultured adipocytes separated according cell size from 30 individuals undergoing elective plastic surgery were investigated.
Results: The mean adipocyte volume of the 4 fractions ranged from 205±146pl to 983±87pl. There were strong linear correlations for the secretion of adipokines over time. Secretion of leptin, IL-6, IL-8, TNF-
, MCP-1, IP-10, MIP-1
, G-CSF, IL-1ra, and adiponectin was positively correlated with cell size. After correction for cell surface, there was still a significant difference between fraction IV (very large) and fraction I (small cells), for leptin, IL-6, IL-8, MCP-1 and G-CSF. In contrast, anti-inflammatory factors such as IL-1ra and adiponectin lost their association size after correction for cell surface area comparing fraction I and IV. In addition, there was a decrease of IL-10 secretion with increasing cell size.
Conclusions: The results clearly suggest that adipocyte size is an important determinant of adipokine secretion. There seems to be a differential expression of pro- and anti-inflammatory factors with increasing adipocyte size resulting in a shift towards dominance of pro-inflammatory adipokines largely due to a dysregulation of hypertrophic, very large cells.
This article has been cited by other articles:
![]() |
G. R. Hajer, T. W. van Haeften, and F. L.J. Visseren Adipose tissue dysfunction in obesity, diabetes, and vascular diseases Eur. Heart J., September 5, 2008; (2008) ehn387v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Birsoy, A. Soukas, J. Torrens, G. Ceccarini, J. Montez, M. Maffei, P. Cohen, G. Fayzikhodjaeva, A. Viale, N. D. Socci, et al. From the Cover: Cellular program controlling the recovery of adipose tissue mass: An in vivo imaging approach PNAS, September 2, 2008; 105(35): 12985 - 12990. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bosutti, G. Malaponte, M. Zanetti, P. Castellino, M. Heer, G. Guarnieri, and G. Biolo Calorie Restriction Modulates Inactivity-Induced Changes in the Inflammatory Markers C-Reactive Protein and Pentraxin-3 J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3226 - 3229. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Kintscher, M. Hartge, K. Hess, A. Foryst-Ludwig, M. Clemenz, M. Wabitsch, P. Fischer-Posovszky, T. F.E. Barth, D. Dragun, T. Skurk, et al. T-lymphocyte Infiltration in Visceral Adipose Tissue: A Primary Event in Adipose Tissue Inflammation and the Development of Obesity-Mediated Insulin Resistance Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1304 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pfleger, H. B. Mortensen, L. Hansen, C. Herder, B. O. Roep, H. Hoey, H.-J. Aanstoot, M. Kocova, N. C. Schloot, and on behalf of the Hvidore Study Group on Childhood Association of IL-1ra and Adiponectin With C-Peptide and Remission in Patients With Type 1 Diabetes Diabetes, April 1, 2008; 57(4): 929 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gustafson, A. Hammarstedt, C. X. Andersson, and U. Smith Inflamed Adipose Tissue: A Culprit Underlying the Metabolic Syndrome and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2276 - 2283. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Maury, K. Ehala-Aleksejev, Y. Guiot, R. Detry, A. Vandenhooft, and S. M. Brichard Adipokines oversecreted by omental adipose tissue in human obesity Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E656 - E665. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Cooper, S. Radom-Aizik, C. Schwindt, and F. Zaldivar Jr. Dangerous exercise: lessons learned from dysregulated inflammatory responses to physical activity J Appl Physiol, August 1, 2007; 103(2): 700 - 709. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |